Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Single Ventricle Fontan Palliation Clear all

Conditions: Single Ventricle
Interventions: Treprostinil; Drug
Lead sponsor: Stanford University; Other
Eligibility: 1 Year to 18 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Single-ventricle
Interventions: Live-Video-Supervised Exercise Intervention, Usual Care then Live-Video Supervised Exercise Intervention; Other
Lead sponsor: Stanford University; Other
Eligibility: 8 Years to 19 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pleural Effusion, Single-ventricle
Interventions: Vasopressin, Normal Saline; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Months to 7 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Oak Lawn, Illinois

Conditions: Single-ventricle, Congenital Heart Disease
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 3 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Single Ventricle Heart Disease After Fontan Surgery
Interventions: Udenafil; Drug
Lead sponsor: Mezzion Pharma Co. Ltd; Industry
Eligibility: 14 Years to 18 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 5
States / cities: Indianapolis, Indiana • Ann Arbor, Michigan • Cincinnati, Ohio + 2 more

Conditions: Tetralogy of Fallot, Transposition of the Great Vessels With an Arterial Switch, Single Ventricle With a Fontan Palliation
Interventions: Eplerenone; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Circulatory Perfusion Disorder, Congenital Heart Disease, Single-ventricle
Interventions: Vasopressin, Arginine, Placebo; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 3 Weeks to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Congenital Disorders
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 18 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1990 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Congenital Heart Disease, Single Ventricle, Myocardial Fibrosis
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Single Ventricle Fontan Palliation
Interventions: Ambrisentan; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Fontan Procedure, Hypoplastic Left Heart Syndrome, Tricuspid Atresia, Double Inlet Left Ventricle
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 10 Years and older
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Congenital Disorders
Interventions: Spironolactone (drug); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Fontan Procedure, Hypoplastic Left Heart Syndrome, Tricuspid Atresia
Interventions: Vitamin C, Placebo; Dietary Supplement
Lead sponsor: University of Michigan; Other
Eligibility: 8 Years to 25 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Functional Single Ventricle Heart Disease
Interventions: Udenafil; Drug
Lead sponsor: Mezzion Pharma Co. Ltd; Industry
Eligibility: 12 Years to 18 Years
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 21
States / cities: Phoenix, Arizona • Los Angeles, California • San Diego, California + 18 more

Conditions: Congenital Heart Disease, SRV Dependent
Interventions: Autologous mononuclear cells; Biological
Lead sponsor: Timothy J Nelson, MD, PhD; Other
Eligibility: 2 Years to 5 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Birmingham, Alabama • Los Angeles, California • Aurora, Colorado + 3 more